Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

34

Portfolio Exits

16

About Vector Fund Management

Vector Fund Management, L.P. is a venture capital firm founded in 1994 and based in Deerfield, Illinois. It specializes in later stage equity invesments in private and public companies, and also invests in negotiated transactions involving securities of small to medium capitalization public companies. The firm typically invests between $5 million and $15 million, focusing on the the healthcare and life sciences industry (in particular biotechnology, pharmaceuticals, medical devices, diagnostics, plant and animal sciences, healthcare services, healthcare information technology, and consumer applications of emerging healthcare technologies).

Vector Fund Management Headquarter Location

1751 Lake Cook Road Suite 350

Deerfield, Illinois, 60015,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Vector Fund Management Investments

34 Investments

Vector Fund Management has made 34 investments. Their latest investment was in CGI Pharmaceuticals as part of their Series C on June 6, 2004.

CBI Logo

Vector Fund Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/24/2004

Series C

CGI Pharmaceuticals

$34.9M

No

1/13/2004

Unattributed VC - III

Cellomics

$5.3M

No

10/22/2003

Unattributed VC - V

Xcyte Therapies

$12.7M

No

8/25/2003

Series C

Subscribe to see more

$99M

Subscribe to see more

0

5/6/2003

Unattributed VC - II

Subscribe to see more

$99M

Subscribe to see more

0

Date

6/24/2004

1/13/2004

10/22/2003

8/25/2003

5/6/2003

Round

Series C

Unattributed VC - III

Unattributed VC - V

Series C

Unattributed VC - II

Company

CGI Pharmaceuticals

Cellomics

Xcyte Therapies

Subscribe to see more

Subscribe to see more

Amount

$34.9M

$5.3M

$12.7M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

Vector Fund Management Portfolio Exits

16 Portfolio Exits

Vector Fund Management has 16 portfolio exits. Their latest portfolio exit was InterMune on August 24, 2014.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/24/2014

Acq - P2P

$99M

1

6/25/2010

Acquired

$99M

1

8/13/2008

Acquired

$99M

5/5/2006

Acquired

Subscribe to see more

Subscribe to see more

0

3/14/2006

Acquired

Subscribe to see more

Subscribe to see more

10

Date

8/24/2014

6/25/2010

8/13/2008

5/5/2006

3/14/2006

Exit

Acq - P2P

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

1

0

10

Vector Fund Management Team

3 Team Members

Vector Fund Management has 3 team members, including former Managing Director, Barclay A. Phillips.

Name

Work History

Title

Status

Barclay A. Phillips

Managing Director

Former

Douglas W. Reed

Managing Director

Former

Ranjan Lal

General Partner

Former

Name

Barclay A. Phillips

Douglas W. Reed

Ranjan Lal

Work History

Title

Managing Director

Managing Director

General Partner

Status

Former

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.